Halbert Hargrove Global Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3
Closed -$713 – 404
2026
Q2
$713 Buy
+3
New +$623 ﹤0.01% 480
2025
Q4
– Sell
-13
Closed -$2.04K – 416
2025
Q3
$2.04K Buy
+13
New +$2.01K ﹤0.01% 558
2025
Q2
– Sell
-4
Closed -$552 – 362
2025
Q1
$552 Buy
+4
New +$510 ﹤0.01% 489
2015
Q3
– Sell
-5,308
Closed -$444K – 108
2015
Q2
$444K Buy
5,308
+86
+2% +$7.59K 0.11% 101
2015
Q1
$471K Buy
5,222
+2,067
+66% +$178K 0.15% 100
2014
Q4
$255K Sell
3,155
-331
-9% -$26.1K 0.13% 107
2014
Q3
$261K Sell
3,486
-82
-2% -$5.97K 0.07% 110
2014
Q2
$245K Buy
3,568
+10
+0.3% +$681 0.07% 100
2014
Q1
$249K Sell
3,558
-215
-6% -$15K 0.08% 100
2013
Q4
$252K Buy
+3,773
New +$231K 0.08% 107

Other funds holding CAH

Halbert Hargrove Global Advisors's CAH Position: Q3 2026 in Review

Halbert Hargrove Global Advisors sold out of Cardinal Health (CAH) in Q3 2026, closing a stake of 3 shares — an estimated $713 sold.

Halbert Hargrove Global Advisors first reported a position in CAH in Q4 2013 and held it in 10 quarters. The position peaked at $471K in Q1 2015. 806 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Halbert Hargrove Global Advisors reported no remaining Cardinal Health position as of Q3 2026 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 3 Cardinal Health shares in Q3 2026, an estimated $713.
  • Halbert Hargrove Global Advisors first reported a position in Cardinal Health in Q4 2013 and held it in 10 quarters.
  • Halbert Hargrove Global Advisors's Cardinal Health position peaked at $471K in Q1 2015.
  • 806 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.